Compare AEHL & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEHL | CELZ |
|---|---|---|
| Founded | 1993 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 6.6M |
| IPO Year | 2009 | 2008 |
| Metric | AEHL | CELZ |
|---|---|---|
| Price | $2.20 | $1.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 8.1M | 20.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.22 |
| 52 Week Low | $0.09 | $1.50 |
| 52 Week High | $8.41 | $6.25 |
| Indicator | AEHL | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 71.01 | 45.89 |
| Support Level | $1.80 | $1.72 |
| Resistance Level | $2.47 | $1.96 |
| Average True Range (ATR) | 0.25 | 0.08 |
| MACD | 0.19 | 0.01 |
| Stochastic Oscillator | 79.06 | 47.62 |
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.